PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 180 filers reported holding PTC THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,256,014 | -43.7% | 100,670 | +2.2% | 0.00% | 0.0% |
| Q2 2023 | $4,007,744 | -24.4% | 98,543 | -9.9% | 0.00% | -50.0% |
| Q1 2023 | $5,298,417 | +61.7% | 109,381 | +27.4% | 0.00% | +100.0% |
| Q4 2022 | $3,276,551 | -19.0% | 85,841 | +6.5% | 0.00% | -50.0% |
| Q3 2022 | $4,045,000 | +11.5% | 80,578 | -11.0% | 0.00% | +100.0% |
| Q2 2022 | $3,628,000 | +6.5% | 90,550 | -0.8% | 0.00% | 0.0% |
| Q1 2022 | $3,407,000 | +0.6% | 91,311 | +7.4% | 0.00% | 0.0% |
| Q4 2021 | $3,385,000 | +6.4% | 85,001 | -0.6% | 0.00% | 0.0% |
| Q3 2021 | $3,182,000 | +66.7% | 85,514 | +89.3% | 0.00% | 0.0% |
| Q2 2021 | $1,909,000 | +6.6% | 45,170 | +19.5% | 0.00% | 0.0% |
| Q1 2021 | $1,790,000 | -27.2% | 37,789 | -6.3% | 0.00% | 0.0% |
| Q4 2020 | $2,460,000 | +54.1% | 40,317 | +18.1% | 0.00% | 0.0% |
| Q3 2020 | $1,596,000 | -35.0% | 34,147 | -29.4% | 0.00% | 0.0% |
| Q2 2020 | $2,456,000 | +31.1% | 48,397 | +16.4% | 0.00% | 0.0% |
| Q1 2020 | $1,873,000 | -1.6% | 41,594 | +4.9% | 0.00% | 0.0% |
| Q4 2019 | $1,904,000 | +60.0% | 39,654 | +12.8% | 0.00% | 0.0% |
| Q3 2019 | $1,190,000 | -24.3% | 35,148 | +0.6% | 0.00% | 0.0% |
| Q2 2019 | $1,572,000 | -35.6% | 34,947 | -46.1% | 0.00% | 0.0% |
| Q1 2019 | $2,441,000 | +416.1% | 64,863 | +369.9% | 0.00% | – |
| Q4 2018 | $473,000 | -14.0% | 13,804 | +17.7% | 0.00% | – |
| Q3 2018 | $550,000 | +49.5% | 11,725 | +7.5% | 0.00% | – |
| Q2 2018 | $368,000 | +19.1% | 10,907 | -4.6% | 0.00% | – |
| Q1 2018 | $309,000 | +86.1% | 11,434 | +14.9% | 0.00% | – |
| Q4 2017 | $166,000 | -10.8% | 9,953 | +5.7% | 0.00% | – |
| Q3 2017 | $186,000 | +24.8% | 9,414 | +16.1% | 0.00% | – |
| Q2 2017 | $149,000 | +91.0% | 8,112 | 0.0% | 0.00% | – |
| Q1 2017 | $78,000 | -17.9% | 8,112 | -5.5% | 0.00% | – |
| Q4 2016 | $95,000 | +48.4% | 8,586 | +60.9% | 0.00% | – |
| Q3 2016 | $64,000 | +10.3% | 5,336 | -34.7% | 0.00% | – |
| Q2 2016 | $58,000 | +11.5% | 8,176 | 0.0% | 0.00% | – |
| Q1 2016 | $52,000 | -75.9% | 8,176 | +21.6% | 0.00% | – |
| Q4 2015 | $216,000 | +24.1% | 6,722 | 0.0% | 0.00% | – |
| Q3 2015 | $174,000 | -46.3% | 6,722 | 0.0% | 0.00% | – |
| Q2 2015 | $324,000 | +20.0% | 6,722 | +57.9% | 0.00% | – |
| Q1 2015 | $270,000 | +48.4% | 4,257 | +25.8% | 0.00% | – |
| Q4 2014 | $182,000 | +22.1% | 3,383 | 0.0% | 0.00% | – |
| Q3 2014 | $149,000 | – | 3,383 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayer Capital Management, LP | 416,666 | $7,153,000 | 38.92% |
| Novo Holdings A/S | 747,359 | $11,210,000 | 2.78% |
| Bain Capital Public Equity Management, LLC | 2,333,333 | $50,073,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,027 | $18,134,000 | 0.84% |
| HealthCor Management, L.P. | 732,200 | $15,713,000 | 0.84% |
| RA Capital Management | 300,000 | $6,438,000 | 0.67% |
| Catalyst Capital Advisors LLC | 30,666 | $658,000 | 0.36% |
| CR Intrinsic Investors, LLC | 119,237 | $2,559,000 | 0.08% |
| Weiss Multi-Strategy Advisers LLC | 284,130 | $6,098,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 57,519 | $1,234,000 | 0.06% |